Group Regeneron Pharmaceuticals, Inc.

Stock

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
803.17 ^USD	+2.49%		+2.93%	+4.06%

13/02	HSBC Adjusts Price Target on Regeneron Pharmaceuticals to $990 From $985, Maintains Buy Rating	MT
12/02	Regeneron Pharmaceuticals Insider Sold Shares Worth $1,585,058, According to a Recent SEC Filing	MT

Company	Manager
Regeneron Ireland DAC Regeneron Ireland DAC Operates as a biotechnology company which develops medicines for serious diseases	Leonard Schleifer